Tumor-Induced Local and Systemic Impact on Blood Vessel Function.

Area of Science:

• Oncology
• Vascular Biology
• Immunology

Background:

• Endothelial dysfunction is implicated in cancer mortality.
• The endothelium acts as a barrier against metastasis and facilitates immune cell entry into tumors.
• Tumor cells manipulate endothelial cells, recruiting leukocytes that promote inflammation and tumorigenesis.

Purpose of the Study:

• To discuss alterations in vascular function in cancer patients.
• To explore the role of leukocytes in mediating tumor-induced vascular effects.

Main Methods:

• Review of current literature on endothelial dysfunction in cancer.
• Analysis of leukocyte-endothelium interactions in primary tumors and distant organs.

Main Results:

• Tumor cells induce endothelial dysfunction, affecting both primary tumor sites and distant organs like the kidney and heart.
• Leukocytes, including neutrophils and macrophages, are key mediators of these tumor-induced vascular changes.
• Impaired vascular function in peripheral organs can contribute to organ failure in cancer patients.

Conclusions:

• Leukocyte-mediated endothelial dysfunction is a significant factor in cancer progression and mortality.
• Understanding these mechanisms is crucial for developing novel cancer therapies targeting vascular function.